Teva Announces FDA Filing Acceptance for AJOVY® » Globe Newswire - TCN.VN

Ingredion Incorporated Reports Strong 2023 Fourth Quarter and Full-Year Results 6-02-2024, 18:05

SiriusPoint reports seventh consecutive quarter of underwriting profits and strong net income at $109.9m 2-08-2024, 03:10

Builder.ai Welcomes Peter Sharples as New VP of Revenue and Partnerships for Asia Pacific 30-11-2023, 17:00

7-04-2025, 18:30

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

Notified -

Globe Newswire7-04-2025, 18:30

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.